Patient-reported outcomes (PROs) in randomised controlled trials in diabetes and pregnancy: protocol for a systematic review

por Newman, Christine, Kgosidialwa, Oratile, Dervan, Louise, Bogdanet, Delia, Egan, Aoife Maria, Biesty, Linda, Devane, Declan, O'Shea, Paula M, Dunne, Fidelma
Publicado 2021

The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland

por Bogdanet, Delia, Toth Castillo, Michelle, Doheny, Helen, Dervan, Louise, Angel Luque-Fernandez, Miguel, Halperin, Jose, O'Shea, Paula M., Dunne, Fidelma P.
Publicado 2022

The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Pros...

por Bogdanet, Delia, Toth Castillo, Michelle, Doheny, Helen, Dervan, Louise, Luque-Fernandez, Miguel-Angel, Halperin, Jose A., O’Shea, Paula M., Dunne, Fidelma P.
Publicado 2022

The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland

por Bogdanet, Delia, Castillo, Michelle Toth, Doheny, Helen, Dervan, Louise, Luque-Fernandez, Miguel Angel, Halperin, Jose A., O’Shea, Paula M., Dunne, Fidelma P.
Publicado 2022